Ontology highlight
ABSTRACT: Objective
Olanzapine and Aripiprazole are widely used second-generation antipsychotic drugs. Olanzapine, more than Aripiprazole, leads to considerable metabolic side effects including obesity and diabetes. While the underlying mechanisms are not fully understood, these side effects are likely associated with mild inflammation in the metabolic organs. An in vitro model that accurately recapitulates the metabolic impact of olanzapine and aripiprazole should be useful to elucidate the underlying mechanisms.Methods
We established co-cultures of matured adipocytes derived from the human SGBS cell line and the THP-1 human monocytic cell-derived or primary macrophages to explore the effects of both drugs on the response to insulin.Results
Olanzapine, but not aripipr
SUBMITTER: Dipta P
PROVIDER: S-EPMC9216267 | biostudies-literature | 2021 Aug
REPOSITORIES: biostudies-literature